Mutant p53 drives ferroptosis resistance through metabolic plasticity in pancreatic cancer
Pancreatic cancer is one of the deadliest malignancies known to medicine, and its resistance to virtually every conventional therapy has ...
Pancreatic cancer is one of the deadliest malignancies known to medicine, and its resistance to virtually every conventional therapy has ...
A groundbreaking first-in-human clinical trial has unveiled promising results for setidegrasib, an innovative therapeutic agent that specifically targets the KRAS ...
In a groundbreaking advancement poised to redefine therapeutic strategies against one of the most lethal forms of cancer, recent research ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine